PetIQ, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 08, 2023 at 09:05 pm
Share
PetIQ, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 314.55 million compared to USD 252.01 million a year ago. Net income was USD 9.47 million compared to USD 4.63 million a year ago. Basic earnings per share from continuing operations was USD 0.32 compared to USD 0.16 a year ago. Diluted earnings per share from continuing operations was USD 0.32 compared to USD 0.16 a year ago.
For the six months, revenue was USD 605.02 million compared to USD 527.71 million a year ago. Net income was USD 19.17 million compared to USD 7.76 million a year ago. Basic earnings per share from continuing operations was USD 0.66 compared to USD 0.27 a year ago. Diluted earnings per share from continuing operations was USD 0.66 compared to USD 0.26 a year ago.
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segmentâs services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.